Aurinia Pharmaceuticals Newsroom

Aurinia Pharmaceuticals Up Nearly 14%, on Pace for Largest Percent Increase Since January 2023 -- Data Talk

Dow JonesDec 10 13:37 ET

Implied Volatility Surging for Aurinia Pharmaceuticals (AUPH) Stock Options

Zacks Dec 10 07:35 ET

Insider Purchase: Director at $AUPH (AUPH) Buys 300,000 Shares

Quiver QuantitativeDec 9 17:02 ET

Aurinia Pharmaceuticals(AUPH.US) Director Buys US$10.82 Million in Common Stock

Moomoo NewsDec 9 16:57 ET

Aurinia Pharmaceuticals Insider Bought Shares Worth $10,822,000, According to a Recent SEC Filing

MT NewswiresDec 9 16:56 ET

Kevin Tang Buys $10.82 Million in Aurinia Pharmaceuticals Shares

InvestingDec 9 16:56 ET

While Institutions Own 40% of Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH), Retail Investors Are Its Largest Shareholders With 52% Ownership

Yahoo FinanceDec 6 09:54 ET

Improved Revenues Required Before Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Stock's 27% Jump Looks Justified

Simply Wall StNov 23 07:31 ET

Insiders At Aurinia Pharmaceuticals Sold US$2.0m In Stock, Alluding To Potential Weakness

Simply Wall StNov 22 05:44 ET

Positive Outlook for Aurinia Pharmaceuticals Boosted by Favorable Lupus Nephritis Guidelines

TipRanksNov 21 01:17 ET

Analysts Offer Insights on Healthcare Companies: Aurinia Pharmaceuticals (AUPH) and Siemens Healthineers AG (OtherSEMHF)

TipRanksNov 19 20:40 ET · Ratings

Aurinia Commends 2024 Updated ACR Guidelines for Screening, Treatment, and Management of Lupus Nephritis

BusinesswireNov 18 17:53 ET

Express News | Aurinia Commends 2024 Updated Acr Guidelines for Screening, Treatment, and Management of Lupus Nephritis

ReutersNov 18 17:53 ET

Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of LUPKYNIS in Managing LN at American College of Rheumatology Convergence 2024

BusinesswireNov 15 06:00 ET

Express News | Aurinia Presents New Data Underscoring Critical Importance of Earlier Lupus Nephritis Detection and Intervention and Value of Lupkynis® in Managing Ln at American College of Rheumatology Convergence 2024

ReutersNov 15 06:00 ET

Aurinia to Participate in Jefferies London Healthcare Conference

BusinesswireNov 14 06:00 ET

RBC Capital Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Raises Target Price to $9

Moomoo NewsNov 11 07:31 ET · Ratings

Bloom Burton Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating, Raises Target Price to $10.85

Moomoo NewsNov 11 04:34 ET · Ratings

Positive Outlook on Aurinia Pharmaceuticals Amid Strong Financial Performance and Strategic Cost Management

TipRanksNov 11 03:35 ET

Leerink Partners Maintains Aurinia Pharmaceuticals(AUPH.US) With Buy Rating

Moomoo NewsNov 8 02:32 ET · Ratings